Concepedia

Bryan K. Kee

BK

Statistics

Publications

47

Citations

2.8K

H-Index

28

Active since

2010

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Guardant (United States)

University of North Carolina at Chapel Hill

University of California San Diego

Methodist Hospital

Bryan K. Kee is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

2010–2025

47

Publications

47

Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment

Maria Pia Morelli, Michael J. Overman, Arvind Dasari et al. · Annals of Oncology · 2015 · 251 citations · Full text

, , +17

Anti-EGFR-resistant clones decay exponentially after progression: implications for anti-EGFR re-challenge

Christine M. Parseghian, Jonathan M. Loree, Van K. Morris et al. · Annals of Oncology · 2018 · 240 citations · Full text

, , +17

Phase IB Study of Vemurafenib in Combination with Irinotecan and Cetuximab in Patients with Metastatic Colorectal Cancer with <i>BRAF</i> V600E Mutation

David S. Hong, Van K. Morris, Badi El Osta et al. · Cancer Discovery · 2016 · 218 citations · Full text

, , +14

Survival improvement for patients with metastatic colorectal cancer over twenty years

Fadl A. Zeineddine, Mohammad A. Zeineddine, Abdelrahman Yousef et al. · npj Precision Oncology · 2023 · 174 citations · Full text

, , +5

Initiative for Molecular Profiling and Advanced Cancer Therapy (IMPACT): An MD Anderson Precision Medicine Study

Apostolia M. Tsimberidou, David S. Hong, Yang Ye et al. · JCO Precision Oncology · 2017 · 161 citations

, , +17

1–5 of 47